Tag Archives: FRI

Jan de Backer, CEO and founder of Fluidda, speaks about the partnership with Materialise at the ATS conference.

De Backer states: “We are very excited and proud to enter into this new phase of partnership with Materialise. We share the vision that the medical field, and particularly respiratory healthcare imaging needs to evolve towards personalized, precision medicine through a value-based healthcare approach. We are confident that advanced imaging techniques, such as our Functional Respiratory Imaging methods, can add value in this regard. “

Friday June 7: Presentation FLUIDDA on CFD and lung deposition at the ECFS 2019 conference in Liverpool

At the yearly conference of the European Cystic Fibrosis Society which takes place from June 5-8 in liverpool (UK), the CEO and founder of Fluidda, Jan de Backer, will present new data obtained bij Functional Respiratory imaging ( FRI) on deposition patterns of CF-medication in the lung, and it’s clinical impact. The presentation will take… Continue Reading

Jan de Backer, CEO and founder of Fluidda, explains the purpose of the FIGHT-project at the ATS conference.

FIGHT is a non-profit charity project which has been established together with FLUIDDA, focusing on research of the lung health of Californian firefighters. The key purpose of the charity is to examine lung diseases rooting from wildfire smoke exposure, investigate how these diseases can be detected earlier on, and determine how treatment protocols can be… Continue Reading

FRI can speed up development of novel treatments for COPD and other lung diseases.

At IRDD, May 30 in New York, Dr. De Backer will discuss the clinical relevance of understanding regional lung structure and function in the development of novel treatments for lung diseases. Functional Respiratory Imaging (FRI) and Artificial Intelligence (AI) can greatly facilitate the development of novel inhaled treatments for COPD and other lung diseases through… Continue Reading

CEO FLUIDDA appointed to Board of Directors of OSIC (Open Source Imaging Consortium)

Jan de Backer, CEO and founder of FLUIDDA, has been appointed to the Board of Directors of the new global non-profit organization OSIC (Open Source Imaging Consortium). The OSIC is a cooperative effort between academia, industry and philanthropy to enable rapid advances in the fight against Idiopathic Pulmonary Fibrosis (IPF) and other progressive interstitial lung… Continue Reading

New study shows that effects of wildfire exposure are more severe than previously anticipated

Study results will be presented at the upcoming ATS conference in Dallas on Sunday, May 19, 2:15-4:15 PM, Trinity Ballroom 5-7: A2480/1001 FLUIDDA, in collaboration with researchers at UC Davis, studied the effect of exposure to airborne particles caused by wildfires in newborn, non-human primates. The study, using Functional Respiratory Imaging, showed significant abnormalities in… Continue Reading

Next week: ATS conference with FLUIDDA booth and new data on FRI -reseach

Next week,  Fluidda will exhibit at the annual American Thoracic Society International Conference ATS 2019 in Dallas, Texas. The ATS, founded in 1905, is the preeminent conference on pulmonary, critical care, and sleep medicine in the United States. It’s where ”today’s science meets tomorrow’s care.” The ATS, founded in 1905, is the preeminent conference on pulmonary, critical care,… Continue Reading

Wednesday May 8 at RDD conference: FLUIDDA Workshop on FRI

From May 7-10 the Annual Respiratory Drug Delivery Congress (RDD) will take place in Estoril, Portugal. During this conference, Fluidda will moderate a workshop on Functional Respiratory Imaging (FRI). The workshop will introduce the different building blocks of FRI aerosol deposition analysis including patient-specific 3D airway geometry modelling, inhaler characteristics and CFD simulations to model… Continue Reading

FLUIDDA at the ATS Conference, May 17-22, Dallas

Next month  Fluidda will exhibit at the annual American Thoracic Society International Conference ATS 2019 in Dallas, Texas. The ATS, founded in 1905, is the preeminent conference on pulmonary, critical care, and sleep medicine in the United States. It’s where ”today’s science meets tomorrow’s care.” One of the posters Fluidda will present is a study using the… Continue Reading

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

All content © FLUIDDA 2019